{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:04:00Z","timestamp":1792623840641,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1436,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/mt.2012.148","type":"journal-article","created":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T12:43:20Z","timestamp":1343738600000},"page":"2043-2051","source":"Crossref","is-referenced-by-count":39,"title":["Oral Administration of Recombinant Adeno-associated Virus-mediated Bone Morphogenetic Protein-7 Suppresses CCl4-induced Hepatic Fibrosis in Mice"],"prefix":"10.1016","volume":"20","author":[{"given":"Zhi-Ming","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2012.148_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2012.148_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11894-009-0080-9","article-title":"Antifibrotic therapies: will we ever get there","volume":"12","author":"Thompson","year":"2010","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1038\/mt.2012.148_bib3","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/hep.1840130628","article-title":"Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver","volume":"13","author":"Geerts","year":"1991","journal-title":"Hepatology"},{"key":"10.1038\/mt.2012.148_bib4","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199306243282508","article-title":"Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies","volume":"328","author":"Friedman","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2012.148_bib5","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2012.148_bib6","doi-asserted-by":"crossref","first-page":"12719","DOI":"10.1073\/pnas.96.22.12719","article-title":"In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis","volume":"96","author":"George","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2012.148_bib7","doi-asserted-by":"crossref","first-page":"G539","DOI":"10.1152\/ajpgi.00436.2002","article-title":"Transforming growth factor-beta1 downregulation of Smad1 gene expression in rat hepatic stellate cells","volume":"285","author":"Shen","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1038\/mt.2012.148_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2005.01192.x","article-title":"Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis","volume":"26","author":"Liu","year":"2006","journal-title":"Liver Int"},{"key":"10.1038\/mt.2012.148_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1101\/gad.8.2.133","article-title":"The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms","volume":"8","author":"Kingsley","year":"1994","journal-title":"Genes Dev"},{"key":"10.1038\/mt.2012.148_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrg837","article-title":"Regulatory phases of early liver development: paradigms of organogenesis","volume":"3","author":"Zaret","year":"2002","journal-title":"Nat Rev Genet"},{"key":"10.1038\/mt.2012.148_bib11","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.V12112392","article-title":"Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy","volume":"12","author":"Wang","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1038\/mt.2012.148_bib12","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1681\/ASN.V13suppl_1s14","article-title":"Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function","volume":"13","author":"Morrissey","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/mt.2012.148_bib13","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1046\/j.1523-1755.2003.00035.x","article-title":"Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy","volume":"63","author":"Wang","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/mt.2012.148_bib14","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm888","article-title":"BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury","volume":"9","author":"Zeisberg","year":"2003","journal-title":"Nat Med"},{"key":"10.1038\/mt.2012.148_bib15","doi-asserted-by":"crossref","first-page":"F1060","DOI":"10.1152\/ajprenal.00191.2002","article-title":"Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models","volume":"285","author":"Zeisberg","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/mt.2012.148_bib16","doi-asserted-by":"crossref","first-page":"L120","DOI":"10.1152\/ajplung.00171.2005","article-title":"BMP-7 opposes TGF-beta1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2","volume":"290","author":"Izumi","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1038\/mt.2012.148_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1164\/rccm.200706-945OC","article-title":"Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis","volume":"177","author":"Myll\u00e4rniemi","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1038\/mt.2012.148_bib18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/gut.2006.092460","article-title":"Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats","volume":"56","author":"Kinoshita","year":"2007","journal-title":"Gut"},{"key":"10.1038\/mt.2012.148_bib19","doi-asserted-by":"crossref","first-page":"23337","DOI":"10.1074\/jbc.M700194200","article-title":"Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition","volume":"282","author":"Zeisberg","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2012.148_bib20","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"Zeisberg","year":"2007","journal-title":"Nat Med"},{"key":"10.1038\/mt.2012.148_bib21","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ndt\/gfp618","article-title":"BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure","volume":"25","author":"Loureiro","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/mt.2012.148_bib22","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ndt\/gfq032","article-title":"BMP-7 stops TGF-[beta] in peritoneal fibrosis","volume":"25","author":"Phillips","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/mt.2012.148_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/08977194.2011.582839","article-title":"Role of TGF-\u00df and BMP7 in the pathogenesis of oral submucous fibrosis","volume":"29","author":"Khan","year":"2011","journal-title":"Growth Factors"},{"key":"10.1038\/mt.2012.148_bib24","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/jcp.10275","article-title":"Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats","volume":"196","author":"Maric","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1038\/mt.2012.148_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF02890000","article-title":"Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis","volume":"56","author":"Ballardini","year":"1988","journal-title":"Virchows Arch, B, Cell Pathol"},{"key":"10.1038\/mt.2012.148_bib26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(01)00260-4","article-title":"Hepatic stellate cell\/myofibroblast subpopulations in fibrotic human and rat livers","volume":"36","author":"Cassiman","year":"2002","journal-title":"J Hepatol"},{"key":"10.1038\/mt.2012.148_bib27","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1007\/s10620-007-9758-8","article-title":"Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells","volume":"52","author":"Tacke","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1038\/mt.2012.148_bib28","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/jhep.2002.32673","article-title":"Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy","volume":"35","author":"Yata","year":"2002","journal-title":"Hepatology"},{"key":"10.1038\/mt.2012.148_bib29","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/hep.22003","article-title":"Liver fibrosis: The hepatocyte revisited","volume":"46","author":"Kowdley","year":"2007","journal-title":"Hepatology"},{"key":"10.1038\/mt.2012.148_bib30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1006\/bbrc.1994.1100","article-title":"Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: high affinity binding to basement membranes","volume":"198","author":"Vukicevic","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2012.148_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1096\/fj.06-6837com","article-title":"BMP-7 functions as a novel hormone to facilitate liver regeneration","volume":"21","author":"Sugimoto","year":"2007","journal-title":"FASEB J"},{"key":"10.1038\/mt.2012.148_bib32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-0029-1216378","article-title":"Elevated serum bone morphogenetic protein 7 levels and clinical outcome in children with biliary atresia","volume":"19","author":"Chayanupatkul","year":"2009","journal-title":"Eur J Pediatr Surg"},{"key":"10.1038\/mt.2012.148_bib33","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0959-437X(96)80064-5","article-title":"Bone morphogenetic proteins in development","volume":"6","author":"Hogan","year":"1996","journal-title":"Curr Opin Genet Dev"},{"key":"10.1038\/mt.2012.148_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1517\/14712598.2011.548799","article-title":"AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application","volume":"11","author":"van der Laan","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"10.1038\/mt.2012.148_bib35","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/2625","article-title":"Peroral gene therapy of lactose intolerance using an adeno-associated virus vector","volume":"4","author":"During","year":"1998","journal-title":"Nat Med"},{"key":"10.1038\/mt.2012.148_bib36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.mpg.0000228118.59853.ba","article-title":"Gene transfer to the gastrointestinal tract after peroral administration of recombinant adeno-associated virus type 2 vectors","volume":"43","author":"Shao","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1038\/mt.2012.148_bib37","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10620-007-9991-1","article-title":"Gene delivery to intestinal epithelial cells in vitro and in vivo with recombinant adeno-associated virus types 1, 2 and 5","volume":"53","author":"Polyak","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1038\/mt.2012.148_bib38","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1126\/science.287.5457.1453","article-title":"An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy","volume":"287","author":"During","year":"2000","journal-title":"Science"},{"key":"10.1038\/mt.2012.148_bib39","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1073\/pnas.061020098","article-title":"FHIT gene therapy prevents tumor development in Fhit-deficient mice","volume":"98","author":"Dumon","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2012.148_bib40","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1089\/10430340260201662","article-title":"Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses","volume":"13","author":"Xin","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.148_bib41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JAD-2004-6504","article-title":"Development of a safe oral Abeta vaccine using recombinant adeno-associated virus vector for Alzheimer's disease","volume":"6","author":"Hara","year":"2004","journal-title":"J Alzheimers Dis"},{"key":"10.1038\/mt.2012.148_bib42","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/hep.20918","article-title":"Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice","volume":"42","author":"Ma","year":"2005","journal-title":"Hepatology"},{"key":"10.1038\/mt.2012.148_bib43","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1096\/fj.06-7685com","article-title":"Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model","volume":"21","author":"Mouri","year":"2007","journal-title":"FASEB J"},{"key":"10.1038\/mt.2012.148_bib44","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0065-3527(08)60574-6","article-title":"Adeno-associated viruses","volume":"25","author":"Berns","year":"1979","journal-title":"Adv Virus Res"},{"key":"10.1038\/mt.2012.148_bib45","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1038\/mt.2012.148_bib46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0009-9120(96)00003-6","article-title":"A simplified method for the analysis of hydroxyproline in biological tissues","volume":"29","author":"Reddy","year":"1996","journal-title":"Clin Biochem"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616322067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616322067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T09:55:59Z","timestamp":1743933359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616322067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1525001616322067"],"URL":"https:\/\/doi.org\/10.1038\/mt.2012.148","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}